Oxford Biomedica

Oxford Biomedica

World Rank (Jan-05-2024)
16,733
Market Cap (Jan-05-2024)
0.250 Billion USD
World Rank (Jul-30-2023)
12,183
Market Cap (Jul-30-2023)
0.545 Billion USD
World Rank (Jan-07-2022)
8,157
Market Cap (Jan-07-2022)
1.283 Billion USD
World Rank (Jan-01-2021)
7,523
Market Cap (Jan-01-2021)
1.115 Billion USD
Headquarters Country
UK
World Region
Europe
World Subregion
Northern Europe
Annual Revenue in USD
179 Million USD
Annual Operating Income in USD
-66 Million USD
Annual Net Income in USD
-50 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
591 Million USD
Total Liabilities in USD
286 Million USD
Total Equity in USD
303 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector
Healthcare
Biotechnology
Company Website
OXFORD BIOMEDICA
Wikipedia
Wikipedia
Yahoo
Yahoo @ Frankfurt
Company Profile

Oxford Biomedica is a Pioneer of gene and cell therapy with a position in Lentiviral Vector Research, Development and Bioprocessing company. It have created a valuable portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders and provide with multiple income streams, consisting of upfront milestone payments, development and production fees and potential royalties on future product sales. The headquarters is in UK.

Founded Year
1995
Stock Exchange
Frankfurt
LSE

Share